DOCSLIB.ORG

Oral Microbiome in HIV-Associated Periodontitis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Oral Microbiome in HIV-Associated Periodontitis Oral microbiome in HIV-associated periodontitis. Marc Noguera-Julian, IrsiCaixa AIDS Research Institute Yolanda Guillén, IrsiCaixa AIDS Research Institute Jessica Peterson, Emory University David Reznik, Emory University Erica V. Harris, Emory University Sandeep J. Joseph, Emory University Javier Rivera, IrsiCaixa AIDS Research Institute Sunil Kannanganat, Emory University Rama Amara, Emory University Minhly Nguyen, Emory University Only first 10 authors above; see publication for full author list. Journal Title: Medicine Volume: Volume 96, Number 12 Publisher: Wolters Kluwer Health | 2017-03, Pages e5821-e5821 Type of Work: Article | Final Publisher PDF Publisher DOI: 10.1097/MD.0000000000005821 Permanent URL: https://pid.emory.edu/ark:/25593/s0xtw Final published version: http://dx.doi.org/10.1097/MD.0000000000005821 Copyright information: © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/). Accessed September 29, 2021 5:15 AM EDT ® Observational Study Medicine OPEN Oral microbiome in HIV-associated periodontitis ∗ Marc Noguera-Julian, PhDa,b,c, , Yolanda Guillén, PhDa,b, Jessica Peterson, BsCd, David Reznik, DDSd,e, Erica V. Harris, BsCf, Sandeep J. Joseph, PhDd, Javier Rivera, MsCa,c, Sunil Kannanganat, PhDd,g, Rama Amara, PhDd,g, Minh Ly Nguyen, MDd, Simon Mutembo, MDh, Roger Paredes, MD, PhDa,b,c,i, ∗ Timothy D. Read, PhDd, Vincent C. Marconi, MDd,g, Abstract HIV-associated periodontal diseases (PD) could serve as a source of chronic inflammation. Here, we sought to characterize the oral microbial signatures of HIV+ and HIV– individuals at different levels of PD severity. This cross-sectional study included both HIV+ and HIV– patients with varying degrees of PD. Two tooth, 2 cheek, and 1 saliva samples were obtained for microbiome analysis. Mothur/SILVADB were used to classify sequences. R/Bioconductor (Vegan, PhyloSeq, and DESeq2) was employed to assess overall microbiome structure differences and differential abundance of bacterial genera between groups. Polychromatic flow cytometry was used to assess immune activation in CD4 and CD8 cell populations. Around 250 cheek, tooth, and saliva samples from 50 participants (40 HIV+ and 10 HIV–) were included. Severity of PD was classified clinically as None/Mild (N), Moderate (M), and Severe (S) with 18 (36%), 16 (32%), and 16 (32%) participants in each category, respectively. Globally, ordination analysis demonstrated clustering by anatomic site (R2=0.25, P<0.001). HIV status and PD severity showed a statistically significant impact on microbiome composition but only accounted for a combined 2% of variation. HIV+ samples were enriched in genera Abiotrophia, Neisseria, Kingella, and unclassified Neisseriaceae and depleted in Leptotrichia and Selenomonas. The Neisseria genus was consistently enriched in HIV+ participants regardless of sampling site and PD level. Immune markers were altered in HIV+ participants but did not show association with the oral microbiome. HIV-associated changes in oral microbiome result in subtle microbial signatures along different stages of PD that are common in independent oral anatomic sites. Abbreviations: HIV = human immunodeficiency virus, CDC/AAP = Centers for Disease Control/American Academy of Periodontology, KEGG = Kyoto Encyclopedia of Genes and Genomes, LEFSE = LDA effect size, PCoA = principal coordinates analysis, PICRUSt = Phylogenetic Investigation of Communities by Reconstruction of Unobserved States, PD = periodontal disease, HAART = highly active antiretroviral therapy, VL = viral load. Keywords: HIV, Neisseria, oral microbiome, periodontal disease Editor: Edwin Leeansyah. TDR and VCM contributed equally. Data availability: Metagenomics raw sequencing data along with sample level metadata have been deposited using the NCBI/SRA Web service and compliance to MIMARKS standard. Data can be accessed using SRA accession SRP079702. Funding: This work was supported by the Emory University Center for AIDS Research (CFAR) (V.C.M., P30AI050409). TR acknowledges funding from Emory University Development Funds. M.N-J, J.R, Y.G. and R.P acknowledge funds from the Gala contra la SIDA 2013 and 2014 editions, the Nit per la Recerca a la Catalunya Central 2015 edition and the Red de investigación en SIDA, RD12/0017/0002 as part of the Plan Nacional R + D + I and cofinanced by the Instituto de Salud Carlos III (ISCIII)- Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER). J.R. is supported through a grant for pre-doctoral studies from Noel Alimentaria to the University of Vic (UVic-UCC). Authorship: VCM and TDR conceived and designed the study. DR recruited the study participants, performed their clinical evaluations and collected samples. VCM, DR, MLN, and SM collected and organized data. DR and JMP processed samples, prepared DNA libraries, and performed sequencing. SK performed the inflammation analysis. MN-J, YG, EVH, and SJJ performed bioinformatics sequence analysis. JR performed statistical analysis (JR under the supervision of MN-J and RP). YG ran functional inference analysis under the supervision of MN-J, RP, VCM, and TDR interpreted results. MN-J, RP, TDR, and VCM wrote manuscript, which was reviewed, edited, and approved by all authors. The authors have no conflicts of interest to disclose. Supplemental Digital Content is available for this article. a IrsiCaixa AIDS Research Institute, Badalona, b University Autònoma de Barcelona, Bellaterra, c University de Vic-University Central de Catalunya, Vic, Catalonia, Spain, d Division of Infectious Diseases, Emory University School of Medicine, e Infectious Diseases Program, Grady Health System, f Department of Biology, Emory University, O. Wayne Rollins Research Center, g Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA, h Ministry of Health, Zambia, i Unitat VIH, Hosp. University Germans Trias i Pujol, Badalona, Catalonia, Spain. ∗ Correspondence: Marc Noguera-Julian, Institut de Recerca de la SIDA IrsiCaixa-HIVACAT, Hospital Universitari Germans Trias i Pujol. Ctra de Canyet s/n., Badalona, Catalonia, Spain (e-mail: [email protected]); Vincent C. Marconi, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA (e-mail: [email protected]). Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. Medicine (2017) 96:12(e5821) Received: 19 May 2016 / Received in final form: 12 December 2016 / Accepted: 13 December 2016 http://dx.doi.org/10.1097/MD.0000000000005821 1 Noguera-Julian et al. Medicine (2017) 96:12 Medicine 1. Introduction blot at any time prior to study entry. HIV– control samples fl were obtained from clinical and research staff at the same Periodontal disease (PD) includes a number of in ammatory- – based conditions such as gingivitis and periodontitis, which are institution. HIV participants were required to demonstrate the most common infectious diseases affecting tooth-supporting HIV seronegativity in the prior 30 days before inclusion in the bone structures. Untreated periodontitis affects more than 700 study by HIV free testing at the Infectious Disease Program Ponce [1] Clinic. million people worldwide, can lead to tooth loss, and has been linked to conditions such as cardiovascular disease, diabetes PD was assessed by the oral exam using the Centers for Disease mellitus, or obesity.[1] Control/merican Academy of Periodontology (CDC/AAP) crite- ria based on the tooth clinical attachment level (CAL) and the Over the last 30 years, severe PD has been associated with HIV [21] infection.[2] Although antiretroviral therapy (ART) preserves and probing pocket depth (PPD): restores immune function and prevents the development of (1) Severe PD (S-PD): both >2 interproximal sites with CAL >6 opportunistic infections, individuals with sustained virological mm and >1 interproximal site with PPD >5mm. suppression continue to experience an increased incidence of age- (2) Moderate PD (M-PD): either >2 interproximal sites with related comorbidities (including PD) with synergistic effects on CAL >4mm or >2 interproximal site with PPD >5mm. survival and quality of life. The determinants, course, and impact (3) Mild/none PD (N-PD): neither S-PD nor M-PD. on other comorbid conditions of severe PD in the setting of ART remain a matter of controversy.[3,4] Exclusion criteria included: (A) fewer than 20 teeth in the In classical microbiology descriptions, increases in Porphyor- oral cavity, (b) need for antibiotic prophylaxis for more than monas gingivalis, Treponema denticola, and Tannerella forsyth- 12hours prior to dental care as per the current American ia, the so-called red complex, were strongly associated with Dental Association guidelines or use of an antibiotic in the destructive PD, whereas predominance of other bacterial 14 days prior to the study visit, (c) use of an antimicrobial – complexes was associated to less severe PD.[5 8] The formation mouth rinse (0.12% chlorhexidine gluconate) 30 days prior to of plaque in mature teeth with an enriched proportion of Gram- the
Load more

Recommended publications
  • July 26, 2017 Bruker Daltonik Gmbh Mr. David Cromwick Director Of
    DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service __________________________________________________________________________________________________________________________ Food and Drug Administration 10903 New Hampshire Avenue Document Control Center – WO66-G609 Silver Spring, MD 20993-0002 July 26, 2017 Bruker Daltonik GmbH Mr. David Cromwick Director of Quality 40 Manning Rd Billerica, MA 01821 US Re: K163536 Trade/Device Name: MALDI Biotyper CA (MBT-CA) System, MBT smart CA System Regulation Number: 21 CFR 866.3361 Regulation Name: Mass spectrometer system for clinical use for the identification of microorganisms Regulatory Class: II Product Code: PEX Dated: December 16, 2016 Received: December 16, 2016 Dear Mr. Cromwick: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls.
    [Show full text]
  • Forensic Microbiology Reveals That Neisseria Animaloris Infections In
    www.nature.com/scientificreports OPEN Forensic microbiology reveals that Neisseria animaloris infections in harbour porpoises follow traumatic Received: 14 February 2019 Accepted: 20 September 2019 injuries by grey seals Published: xx xx xxxx Geofrey Foster 1, Adrian M. Whatmore2, Mark P. Dagleish3, Henry Malnick4, Maarten J. Gilbert5, Lineke Begeman6, Shaheed K. Macgregor7, Nicholas J. Davison1, Hendrik Jan Roest8, Paul Jepson7, Fiona Howie9, Jakub Muchowski2, Andrew C. Brownlow1, Jaap A. Wagenaar5,8, Marja J. L. Kik10, Rob Deaville7, Mariel T. I. ten Doeschate1, Jason Barley1,11, Laura Hunter1 & Lonneke L. IJsseldijk 10 Neisseria animaloris is considered to be a commensal of the canine and feline oral cavities. It is able to cause systemic infections in animals as well as humans, usually after a biting trauma has occurred. We recovered N. animaloris from chronically infamed bite wounds on pectoral fns and tailstocks, from lungs and other internal organs of eight harbour porpoises. Gross and histopathological evidence suggest that fatal disseminated N. animaloris infections had occurred due to traumatic injury from grey seals. We therefore conclude that these porpoises survived a grey seal predatory attack, with the bite lesions representing the subsequent portal of entry for bacteria to infect the animals causing abscesses in multiple tissues, and eventually death. We demonstrate that forensic microbiology provides a useful tool for linking a perpetrator to its victim. Moreover, N. animaloris should be added to the list of potential zoonotic bacteria following interactions with seals, as the fnding of systemic transfer to the lungs and other tissues of the harbour porpoises may suggest a potential to do likewise in humans.
    [Show full text]
  • Bacterial Diversity and Functional Analysis of Severe Early Childhood
    www.nature.com/scientificreports OPEN Bacterial diversity and functional analysis of severe early childhood caries and recurrence in India Balakrishnan Kalpana1,3, Puniethaa Prabhu3, Ashaq Hussain Bhat3, Arunsaikiran Senthilkumar3, Raj Pranap Arun1, Sharath Asokan4, Sachin S. Gunthe2 & Rama S. Verma1,5* Dental caries is the most prevalent oral disease afecting nearly 70% of children in India and elsewhere. Micro-ecological niche based acidifcation due to dysbiosis in oral microbiome are crucial for caries onset and progression. Here we report the tooth bacteriome diversity compared in Indian children with caries free (CF), severe early childhood caries (SC) and recurrent caries (RC). High quality V3–V4 amplicon sequencing revealed that SC exhibited high bacterial diversity with unique combination and interrelationship. Gracillibacteria_GN02 and TM7 were unique in CF and SC respectively, while Bacteroidetes, Fusobacteria were signifcantly high in RC. Interestingly, we found Streptococcus oralis subsp. tigurinus clade 071 in all groups with signifcant abundance in SC and RC. Positive correlation between low and high abundant bacteria as well as with TCS, PTS and ABC transporters were seen from co-occurrence network analysis. This could lead to persistence of SC niche resulting in RC. Comparative in vitro assessment of bioflm formation showed that the standard culture of S. oralis and its phylogenetically similar clinical isolates showed profound bioflm formation and augmented the growth and enhanced bioflm formation in S. mutans in both dual and multispecies cultures. Interaction among more than 700 species of microbiota under diferent micro-ecological niches of the human oral cavity1,2 acts as a primary defense against various pathogens. Tis has been observed to play a signifcant role in child’s oral and general health.
    [Show full text]
  • ( 12 ) United States Patent
    US009956282B2 (12 ) United States Patent ( 10 ) Patent No. : US 9 ,956 , 282 B2 Cook et al. (45 ) Date of Patent: May 1 , 2018 ( 54 ) BACTERIAL COMPOSITIONS AND (58 ) Field of Classification Search METHODS OF USE THEREOF FOR None TREATMENT OF IMMUNE SYSTEM See application file for complete search history . DISORDERS ( 56 ) References Cited (71 ) Applicant : Seres Therapeutics , Inc. , Cambridge , U . S . PATENT DOCUMENTS MA (US ) 3 ,009 , 864 A 11 / 1961 Gordon - Aldterton et al . 3 , 228 , 838 A 1 / 1966 Rinfret (72 ) Inventors : David N . Cook , Brooklyn , NY (US ) ; 3 ,608 ,030 A 11/ 1971 Grant David Arthur Berry , Brookline, MA 4 ,077 , 227 A 3 / 1978 Larson 4 ,205 , 132 A 5 / 1980 Sandine (US ) ; Geoffrey von Maltzahn , Boston , 4 ,655 , 047 A 4 / 1987 Temple MA (US ) ; Matthew R . Henn , 4 ,689 ,226 A 8 / 1987 Nurmi Somerville , MA (US ) ; Han Zhang , 4 ,839 , 281 A 6 / 1989 Gorbach et al. Oakton , VA (US ); Brian Goodman , 5 , 196 , 205 A 3 / 1993 Borody 5 , 425 , 951 A 6 / 1995 Goodrich Boston , MA (US ) 5 ,436 , 002 A 7 / 1995 Payne 5 ,443 , 826 A 8 / 1995 Borody ( 73 ) Assignee : Seres Therapeutics , Inc. , Cambridge , 5 ,599 ,795 A 2 / 1997 McCann 5 . 648 , 206 A 7 / 1997 Goodrich MA (US ) 5 , 951 , 977 A 9 / 1999 Nisbet et al. 5 , 965 , 128 A 10 / 1999 Doyle et al. ( * ) Notice : Subject to any disclaimer , the term of this 6 ,589 , 771 B1 7 /2003 Marshall patent is extended or adjusted under 35 6 , 645 , 530 B1 . 11 /2003 Borody U .
    [Show full text]
  • Atypical, Yet Not Infrequent, Infections with Neisseria Species
    pathogens Review Atypical, Yet Not Infrequent, Infections with Neisseria Species Maria Victoria Humbert * and Myron Christodoulides Molecular Microbiology, School of Clinical and Experimental Sciences, University of Southampton, Faculty of Medicine, Southampton General Hospital, Southampton SO16 6YD, UK; [email protected] * Correspondence: [email protected] Received: 11 November 2019; Accepted: 18 December 2019; Published: 20 December 2019 Abstract: Neisseria species are extremely well-adapted to their mammalian hosts and they display unique phenotypes that account for their ability to thrive within niche-specific conditions. The closely related species N. gonorrhoeae and N. meningitidis are the only two species of the genus recognized as strict human pathogens, causing the sexually transmitted disease gonorrhea and meningitis and sepsis, respectively. Gonococci colonize the mucosal epithelium of the male urethra and female endo/ectocervix, whereas meningococci colonize the mucosal epithelium of the human nasopharynx. The pathophysiological host responses to gonococcal and meningococcal infection are distinct. However, medical evidence dating back to the early 1900s demonstrates that these two species can cross-colonize anatomical niches, with patients often presenting with clinically-indistinguishable infections. The remaining Neisseria species are not commonly associated with disease and are considered as commensals within the normal microbiota of the human and animal nasopharynx. Nonetheless, clinical case reports suggest that they can behave as opportunistic pathogens. In this review, we describe the diversity of the genus Neisseria in the clinical context and raise the attention of microbiologists and clinicians for more cautious approaches in the diagnosis and treatment of the many pathologies these species may cause. Keywords: Neisseria species; Neisseria meningitidis; Neisseria gonorrhoeae; commensal; pathogenesis; host adaptation 1.
    [Show full text]
  • Substantial Equivalence Determination Decision Summary
    510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY A. 510(k) K163536 B. Purpose for Submission: To obtain a substantial equivalent determination for the MALDI Biotyper CA System. C. Measurand: See Intended Use. D. Type of Test: The MALDI Biotyper CA System is a qualitative in vitro diagnostic device intended for the identification of Gram-negative bacterial colonies cultured from human specimens. The device is comprised of an ionization source, a mass analyzer and a spectral database. The device is indicated for use in conjunction with other clinical and laboratory findings to aid in the diagnosis of Gram-negative bacterial infections. E. Applicant: Bruker Daltonik GmbH F. Proprietary and Established Names: Trade Name: MALDI Biotyper CA (MBT-CA) System, MBT smart CA System Common Names: MBT-CA, System, mass spectrometry G. Regulatory Information: 1. Regulation section: 21 CFR 866.3361 Instrumentation for clinical multiplex test systems 2. Classification: Class II (special controls) 3. Product code: PEX 4. Panel: Microbiology (83) H. Intended Use: 1. Intended use(s): The MALDI Biotyper CA System is a mass spectrometer system using matrix-assisted laser desorption/ionization - time of flight (MALDI-TOF) for the identification of microorganisms cultured from human specimens. The MALDI Biotyper CA System is a qualitative in vitro diagnostic device indicated for use in conjunction with other clinical and laboratory findings to aid in the diagnosis of bacterial and yeast infections. The following organisms are claimed: 1 Bacteria:
    [Show full text]
  • A Genomic Approach to Bacterial Taxonomy: an Examination and Proposed Reclassification of Species Within the Genus Neisseria
    Microbiology (2012), 158, 1570–1580 DOI 10.1099/mic.0.056077-0 A genomic approach to bacterial taxonomy: an examination and proposed reclassification of species within the genus Neisseria Julia S. Bennett,1 Keith A. Jolley,1 Sarah G. Earle,1 Craig Corton,2 Stephen D. Bentley,2 Julian Parkhill2 and Martin C. J. Maiden1 Correspondence 1Department of Zoology, University of Oxford, Oxford OX1 3PS, UK Julia S. Bennett 2The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK [email protected] In common with other bacterial taxa, members of the genus Neisseria are classified using a range of phenotypic and biochemical approaches, which are not entirely satisfactory in assigning isolates to species groups. Recently, there has been increasing interest in using nucleotide sequences for bacterial typing and taxonomy, but to date, no broadly accepted alternative to conventional methods is available. Here, the taxonomic relationships of 55 representative members of the genus Neisseria have been analysed using whole-genome sequence data. As genetic material belonging to the accessory genome is widely shared among different taxa but not present in all isolates, this analysis indexed nucleotide sequence variation within sets of genes, specifically protein-coding genes that were present and directly comparable in all isolates. Variation in these genes identified seven species groups, which were robust to the choice of genes and phylogenetic clustering methods used. The groupings were largely, but not completely, congruent with current species designations, with some minor changes in nomenclature and the reassignment of a few isolates necessary. In particular, these data showed that isolates classified as Neisseria polysaccharea are polyphyletic and probably include more than one taxonomically distinct organism.
    [Show full text]
  • STUDIES of NEISSERIA MUSCULI TYPE IV PILUS and CAPSULE USING the NATURAL MOUSE MODEL of COLONIZATION and PERSISTENCE by Man Cheo
    Studies of Neisseria musculi Type IV Pilus and Capsule Using the Natural Mouse Model of Colonization and Persistence Item Type text; Electronic Dissertation Authors Ma, Man Cheong Publisher The University of Arizona. Rights Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction, presentation (such as public display or performance) of protected items is prohibited except with permission of the author. Download date 27/09/2021 11:29:10 Link to Item http://hdl.handle.net/10150/634345 STUDIES OF NEISSERIA MUSCULI TYPE IV PILUS AND CAPSULE USING THE NATURAL MOUSE MODEL OF COLONIZATION AND PERSISTENCE by Man Cheong Ma Copyright © Man Cheong Ma 2019 A Dissertation Submitted to the Faculty of the DEPARTMENT OF IMMUNOBIOLOGY In Partial Fulfillment of the Requirements For the Degree of DOCTOR OF PHILOSOPHY In the Graduate College THE UNIVERSITY OF ARIZONA 2019 2 3 Table of Contents List of Figures ................................................................................................................................6 List of Tables ..................................................................................................................................7 Abstract ...........................................................................................................................................8 Chapter 1- Introduction .....................................................................................................................
    [Show full text]
  • The Effect of Calcium Binding on Adhesion and Pilus Biogenesis in the Pilc Family of Proteins
    The Effect of Calcium Binding on Adhesion and Pilus Biogenesis in the PilC Family of Proteins Michael D. L. Johnson A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Biochemistry and Biophysics. Chapel Hill 2011 Approved by: Professor Matthew Redinbo, Ph.D. Professor Edward Collins, Ph.D. Professor Matthew Wolfgang, Ph.D. Professor Jack Griffith, Ph.D. Professor Joseph St. Geme III, M.D. ©2011 Michael D. L. Johnson ALL RIGHTS RESERVED ii ABSTRACT MICHAEL D. L. JOHNSON: The Effect of Calcium Binding on Adhesion and Pilus Biogenesis in the PilC Family of Proteins (Under the direction of Matthew Redinbo) Pseudomonas aeruginosa is an opportunistic pathogen prevalent in people on immunosuppressants, recent open wounds, or cystic fibrosis patients. P. aeruginosa attaches to the host cell via polar type IV pili (tfp). These tfp are composed of many proteins including the major pilus subunit PilA, retraction protein PilT, and one focus of this dissertation, 1163 residue protein PilY1. PilY1 shares homology to other bacterial adhesion and pilus biogenesis proteins such as the PilC family of proteins in Neisseria gonorrhoeae, Neisseria meningitidis, and Kingella kingae thus, it is often characterized as a pilus biogenesis protein and the P. aeruginosa adhesin. However, no known mechanism for either situation had been elucidated. In this study, we have identified two calcium binding sites which affect both functional pilus biogenesis and adhesion to host cells. In addition, we have also located an RGD (integrin binding motif) that mediates PilY1 binding to integrin.
    [Show full text]
  • Evaluation of Microbial Load in Oropharyngeal Mucosa from Tannery Workers
    Safety and Health at Work 6 (2015) 62e70 Contents lists available at ScienceDirect Safety and Health at Work journal homepage: www.e-shaw.org Original Article Evaluation of Microbial Load in Oropharyngeal Mucosa from Tannery Workers Diana C. Castellanos-Arévalo 1, Andrea P. Castellanos-Arévalo 1, David A. Camarena-Pozos 1, Juan G. Colli-Mull 2, María Maldonado-Vega 3,* 1 Departamento de Investigación en Ambiental, Centro de Innovación Aplicada en Tecnologías Competitivas (CIATEC, AC), León, Guanajuato, Mexico 2 Departamento de Biología, Instituto Tecnológico Superior de Irapuato (ITESI), Irapuato, Guanajuato, Mexico 3 Dirección de Enseñanza e Investigación, Hospital Regional de Alta Especialidad del Bajío. León, Guanajuato, México article info abstract Article history: Background: Animal skin provides an ideal medium for the propagation of microorganisms and it is used Received 10 July 2014 like raw material in the tannery and footware industry. The aim of this study was to evaluate and identify Received in revised form the microbial load in oropharyngeal mucosa of tannery employees. 5 September 2014 Methods: The health risk was estimated based on the identification of microorganisms found in the Accepted 17 September 2014 oropharyngeal mucosa samples. The study was conducted in a tanners group and a control group. Available online 7 October 2014 Samples were taken from oropharyngeal mucosa and inoculated on plates with selective medium. In the samples, bacteria were identified by 16S ribosomal DNA analysis and the yeasts through a presumptive Keywords: diarrheal diseases method. In addition, the sensitivity of these microorganisms to antibiotics/antifungals was evaluated. fi opportunistic microorganisms Results: The identi ed bacteria belonged to the families Enterobacteriaceae, Pseudomonadaceae, Neis- oropharyngeal mucosa seriaceae, Alcaligenaceae, Moraxellaceae, and Xanthomonadaceae, of which some species are considered respiratory diseases as pathogenic or opportunistic microorganisms; these bacteria were not present in the control group.
    [Show full text]
  • WO 2015/071474 A2 21 May 2015 (21.05.2015) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2015/071474 A2 21 May 2015 (21.05.2015) P O P C T (51) International Patent Classification: Krzysztof; Simmeringer Hauptstrasse 45/8, A-1 110 Vi C12N 15/11 (2006.01) enna (AT). FONFARA, Ines; Helmstedter Strasse 144, 38102 Braunschweig (DE). (21) International Application Number: PCT/EP2014/074813 (74) Agent: PILKINGTON, Stephanie Joan; Potter Clarkson LLP, The Belgrave Centre, Talbot Street, Nottingham NG1 (22) International Filing Date: 5GG (GB). 17 November 2014 (17.1 1.2014) (81) Designated States (unless otherwise indicated, for every (25) Filing Language: English kind of national protection available): AE, AG, AL, AM, (26) Publication Language: English AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (30) Priority Data: DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, 61/905,835 18 November 2013 (18. 11.2013) US HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (71) Applicant: CRISPR THERAPEUTICS AG [CH/CH]; KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, Aeschenvorstadt 36, CH-4051 Basel (CH). MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, (72) Inventors: CHARPENTIER, Emmanuelle; Boeckler- SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, strasse 18, 38102 Braunschweig (DE).
    [Show full text]
  • ID 6 | Issue No: 3 | Issue Date: 26.06.15 | Page: 1 of 29 © Crown Copyright 2015 Identification of Neisseria Species
    UK Standards for Microbiology Investigations Identification of Neisseria species Issued by the Standards Unit, Microbiology Services, PHE Bacteriology – Identification | ID 6 | Issue no: 3 | Issue date: 26.06.15 | Page: 1 of 29 © Crown copyright 2015 Identification of Neisseria species Acknowledgments UK Standards for Microbiology Investigations (SMIs) are developed under the auspices of Public Health England (PHE) working in partnership with the National Health Service (NHS), Public Health Wales and with the professional organisations whose logos are displayed below and listed on the website https://www.gov.uk/uk- standards-for-microbiology-investigations-smi-quality-and-consistency-in-clinical- laboratories. SMIs are developed, reviewed and revised by various working groups which are overseen by a steering committee (see https://www.gov.uk/government/groups/standards-for-microbiology-investigations- steering-committee). The contributions of many individuals in clinical, specialist and reference laboratories who have provided information and comments during the development of this document are acknowledged. We are grateful to the Medical Editors for editing the medical content. For further information please contact us at: Standards Unit Microbiology Services Public Health England 61 Colindale Avenue London NW9 5EQ E-mail: [email protected] Website: https://www.gov.uk/uk-standards-for-microbiology-investigations-smi-quality- and-consistency-in-clinical-laboratories PHE Publications gateway number: 2015013 UK Standards for Microbiology Investigations are produced in association with: Logos correct at time of publishing. Bacteriology – Identification | ID 6 | Issue no: 3 | Issue date: 26.06.15 | Page: 2 of 29 UK Standards for Microbiology Investigations | Issued by the Standards Unit, Public Health England Identification of Neisseria species Contents ACKNOWLEDGMENTS .........................................................................................................
    [Show full text]